These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7243840)

  • 1. The effect of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats.
    Commissaris RL; Lyness WH; Rech RH
    Pharmacol Biochem Behav; 1981 May; 14(5):617-23. PubMed ID: 7243840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats.
    Commissaris RL; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 May; 14(5):595-601. PubMed ID: 7243838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.
    Kilts CD; Commissaris RL; Cordon JJ; Rech RH
    Psychopharmacology (Berl); 1982; 78(2):156-64. PubMed ID: 6217479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ; Rech RH
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
    Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
    Eckler JR; Chang-Fong J; Rabin RA; Smith C; Teitler M; Glennon RA; Winter JC
    Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM).
    Mokler DJ; Stoudt KW; Sherman LC; Rech RH
    Pharmacol Biochem Behav; 1987 Nov; 28(3):327-34. PubMed ID: 3685066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
    Doat MM; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 Feb; 74(3):713-21. PubMed ID: 12543238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of psychotomimetics and anxiolytics on punished and unpunished responding maintained by fixed interval schedules of food reinforcement in the rat.
    Evenden J; Duncan B; Ko T
    Behav Pharmacol; 2006 Feb; 17(1):87-99. PubMed ID: 16377966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.
    Romano AG; Quinn JL; Li L; Dave KD; Schindler EA; Aloyo VJ; Harvey JA
    Psychopharmacology (Berl); 2010 Oct; 212(3):441-8. PubMed ID: 20827462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
    Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of apomorphine on punished and unpunished responding in the rat.
    McMillan DE; Evans RL
    Pharmacol Biochem Behav; 1988 Jul; 30(3):753-4. PubMed ID: 3211984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.